Back to Search
Start Over
Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype OxfoRd Asthma attaCk risk scaLE (ORACLE)
- Publication Year :
- 2022
- Publisher :
- European Respiratory Society, 2022.
-
Abstract
- The prototype ORACLE scale based on two simple measures of type 2 airway inflammation (blood eosinophils and FENO) quantifies the excess risk conferred by raised biomarkers that is removed by type-2 anti-inflammatory treatment in trial populations
- Subjects :
- Pulmonary and Respiratory Medicine
Subjects
Details
- Language :
- English
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....b54371a25f811967f65e6afcda1b8ce8